OPEN APP
Home / Markets / Stock Markets /  Supriya Lifescience IPO subscription ends today. GMP, other details in 10 points
Listen to this article

Supriya Lifescience IPO opened for subscription on 16th December 2021 and it will remain open for bidding till 20th December 2021 i.e. bidders have just one day in hand to apply for the public issue. Price band of the book built issue has been fixed at 265 to 274 per equity share. The Active pharmaceutical ingredients (APIs) manufacturer company aims to raise 700 crore from its public offer ( 200 crore from fresh issue and 500 crore through Offer for Sale or OFS). According to market observers, shares of Supriya Lifescience are trading at a premium of 180 in grey market today.

Supriya Lifescience IPO subscription status

On Day  of subscription by 11:53 AM, the public issue has been subscribed 9.07 times whereas the retail portion of the issue has been subscribed 37.30 times. 

Here we list out important Supriya Lifescience IPO details in 10 points:

1] Supriya Lifescience IPO GMP: As per market observers, Supriya Lifescience IPO grey market premium (GMP) today is 180 that means grey market is expecting Supriya Lifescience share listing at around 454 ( 274 + 180).

2] Supriya Lifescience IPO subscribe or not: On Supriya Lifescience IPO review; Abhay Doshi, Founder at UnlistedArena.com said, "On the operational front, there is visible growth in top and bottom line as the revenue grew over 22.78%, EBITDA over 62% and PAT grew over 68% from FY20 to FY21.If we annualize 6MFY22 earnings the asking P/E comes around 16.70x (Post Issue) which seems to be reasonable. Attributing to growth, attractive pricing and small sized issue, we may see a very strong interest from the participants."

Ankur Saraswat, Research Analyst at Trustline Securities said, "Company is one of the leading API manufacturers and largest exporters of HCL and Salbutamol Sulphate in India. It has backward integrated business and diversified products portfolio of 38 APIs with a long list of 1296 customers. The company has global presence in 86 countries. It has advanced manufacturing and research and development capabilities and strong financial performance. So, sentiments are bullish on this niche APIs products based IPO."

3] Supriya Lifescience IPO price band: The API manufacturer company has fixed price band of its offer at 265 to 274 per equity share.

4] Supriya Lifescience IPO size: The API maker company aims to raise 700 crore from its public offer ( 200 crore from fresh issue and 500 crore through Offer for Sale or OFS).

5] Supriya Lifescience IPO lot size: A bidder will be able to apply for the IPO in lots and one lot will comprise 54 company shares.

6] Supriya Lifescience IPO application limit: A bidder can apply for minimum one lot and maximum 13 lots.

7] Supriya Lifescience IPO investment limit: As one bidder can apply for minimum one lot and maximum 13 lots, minimum amount required to apply for the IPO is 14,796 ( 174 x 54) whereas maximum investment allowed in the IPO is 1,92,348 [( 274 x 54) x 13].

8] Supriya Lifescience IPO allotment date: The tentative date for share allocation is 23rd December 2021. Initiation of refund may begin in 24th December and credit of shares in the Demat Account of allottees is expected on 27th December 2021.

9] Supriya Lifescience IPO listing: Shares of the company will be listed on both NSE and BSE.

10] Supriya Lifescience IPO listing date: Expected date for share listing of the company is 28th December 2021.

Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint.

Subscribe to Mint Newsletters
* Enter a valid email
* Thank you for subscribing to our newsletter.
Close
Recommended For You
×
Edit Profile
Get alerts on WhatsApp
Set Preferences My ReadsFeedbackRedeem a Gift CardLogout